P2RY12 and atrial fibrillation: Guidelines recommend choosing either dual antithrombotic therapy [DAT: (N)OAC + P2Y12 inhibitor] or triple antithrombotic therapy [TAT: (N)OAC + P2Y12 inhibitor + aspirin] for AF and ACS patients (4, 5, 139, 146, 149).